Immunofluorescence: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
Line 2: Line 2:
{{CMG}}
{{CMG}}


{{Editor Help}}
 
==Overview==
==Overview==
'''Immunofluorescence''' is the labeling of [[antibody|antibodies]] or [[antigens]] with [[Fluorescence|fluorescent]] [[dye]]s.  This technique is often used to visualize subcellular distribution of [[biomolecules]] of interest.  Immunofluorescent labelled tissue sections are studied using a [[fluorescence microscope]] or by [[confocal microscopy]].
'''Immunofluorescence''' is the labeling of [[antibody|antibodies]] or [[antigens]] with [[Fluorescence|fluorescent]] [[dye]]s.  This technique is often used to visualize subcellular distribution of [[biomolecules]] of interest.  Immunofluorescent labelled tissue sections are studied using a [[fluorescence microscope]] or by [[confocal microscopy]].
Line 32: Line 32:
[[Category:Anatomical pathology]]
[[Category:Anatomical pathology]]


{{SIB}}
 
[[pt:Imunofluorescência]]
[[pt:Imunofluorescência]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 16:19, 9 August 2012

WikiDoc Resources for Immunofluorescence

Articles

Most recent articles on Immunofluorescence

Most cited articles on Immunofluorescence

Review articles on Immunofluorescence

Articles on Immunofluorescence in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Immunofluorescence

Images of Immunofluorescence

Photos of Immunofluorescence

Podcasts & MP3s on Immunofluorescence

Videos on Immunofluorescence

Evidence Based Medicine

Cochrane Collaboration on Immunofluorescence

Bandolier on Immunofluorescence

TRIP on Immunofluorescence

Clinical Trials

Ongoing Trials on Immunofluorescence at Clinical Trials.gov

Trial results on Immunofluorescence

Clinical Trials on Immunofluorescence at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Immunofluorescence

NICE Guidance on Immunofluorescence

NHS PRODIGY Guidance

FDA on Immunofluorescence

CDC on Immunofluorescence

Books

Books on Immunofluorescence

News

Immunofluorescence in the news

Be alerted to news on Immunofluorescence

News trends on Immunofluorescence

Commentary

Blogs on Immunofluorescence

Definitions

Definitions of Immunofluorescence

Patient Resources / Community

Patient resources on Immunofluorescence

Discussion groups on Immunofluorescence

Patient Handouts on Immunofluorescence

Directions to Hospitals Treating Immunofluorescence

Risk calculators and risk factors for Immunofluorescence

Healthcare Provider Resources

Symptoms of Immunofluorescence

Causes & Risk Factors for Immunofluorescence

Diagnostic studies for Immunofluorescence

Treatment of Immunofluorescence

Continuing Medical Education (CME)

CME Programs on Immunofluorescence

International

Immunofluorescence en Espanol

Immunofluorescence en Francais

Business

Immunofluorescence in the Marketplace

Patents on Immunofluorescence

Experimental / Informatics

List of terms related to Immunofluorescence

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Immunofluorescence is the labeling of antibodies or antigens with fluorescent dyes. This technique is often used to visualize subcellular distribution of biomolecules of interest. Immunofluorescent labelled tissue sections are studied using a fluorescence microscope or by confocal microscopy.

Most commonly, immunofluorescence employs two sets of antibodies: a primary antibody is used against the antigen of interest; a subsequent, secondary, dye-coupled antibody is introduced that recognizes the primary antibody. In this fashion the researcher may create several primary antibodies that recognize various antigens, but, because they all share a common constant region, may be recognized by a single dye-coupled antibody. Typically this is done by using antibodies made in different species. For example, a researcher might create antibodies in a goat that recognize several antigens, and then employ dye-coupled rabbit antibodies that recognize the goat antibody constant region (denoted rabbit anti-goat). This allows re-use of the difficult-to-make dye-coupled antibodies in multiple experiments.

In some cases, it is advantageous to use primary antibodies directly labelled with a fluorophore. This direct labelling decreases the number of steps in the staining procedure and, more importantly, often avoids cross-reactivity and high background problems. Fluorescent labelling can be performed in less than one hour with readily available labeling kits.

As with most fluorescence techniques, a significant problem with immunofluorescence is photobleaching. Loss of activity caused by photobleaching can be controlled by reducing the intensity or time-span of light exposure, by increasing the concentration of fluorophores, or by employing more robust fluorophores that are less prone to bleaching (e.g. Alexa Fluors or DyLight Fluors).

Many uses of immunofluorescence have been outmoded by the development of recombinant proteins containing fluorescent protein domains, e.g. green fluorescent protein (GFP). Use of such "tagged" proteins allows much better localization and less disruption of protein function.

External links

Template:Pathology

Template:WikiDoc Sources